All authors: Northern Clinical School Intensive Care Research Unit, University of Sydney, Sydney, NSW, Australia.
Crit Care Med. 2018 Jul;46(7):1049-1056. doi: 10.1097/CCM.0000000000003152.
To identify, appraise, and synthesize the most current evidence to determine whether early enteral nutrition alters patient outcomes from critical illness.
Medline and Embase were searched. The close out date was November 20, 2017.
Early enteral nutrition was defined as a standard formula commenced within 24 hours of ICU admission. Comparators included any form of nutrition support "except" early enteral nutrition. Only randomized controlled trials conducted in adult patients requiring treatment in an ICU were eligible for inclusion.
The primary outcome was mortality. Secondary outcomes included pneumonia, duration of mechanical ventilation, and ICU and hospital stay.
Six-hundred ninety-nine full-text articles were retrieved and screened. Sixteen randomized controlled trials enrolling 3,225 critically ill participants were included. Compared with all other types of nutrition support, commencing enteral nutrition within 24 hours of ICU admission did not result in a reduction in mortality (odds ratio, 1.01; 95% CI, 0.86-1.18; p = 0.91; I = 32%). However, there was a differential treatment effect between a priori identified subgroups (p = 0.032): early enteral nutrition reduced mortality compared with delayed enteral intake (odds ratio, 0.45; 95% CI, 0.21-0.95; p = 0.038; I = 0%), whereas a mortality difference was not detected between early enteral nutrition and parenteral nutrition (odds ratio, 1.04; 95% CI, 0.89-1.22; p = 0.58; I = 30%). Overall, patients who were randomized to receive early enteral nutrition were less likely to develop pneumonia (odds ratio, 0.75; 95% CI, 0.60-0.94; p = 0.012; I = 48%).
Overall, there was no difference between early enteral nutrition and all other forms of nutrition support. A priori planned subgroup analysis revealed early enteral nutrition reduced mortality and pneumonia compared with delayed enteral intake; however, there were no clear clinical advantages of early enteral nutrition over parenteral nutrition.
确定、评估并综合目前最新的证据,以明确早期肠内营养是否能改变危重症患者的结局。
检索了 Medline 和 Embase。截止日期为 2017 年 11 月 20 日。
早期肠内营养定义为 ICU 入院后 24 小时内开始给予标准配方。对照组包括任何形式的营养支持“除外”早期肠内营养。仅纳入在 ICU 接受治疗的成年患者进行的随机对照试验。
主要结局是死亡率。次要结局包括肺炎、机械通气时间、ICU 住院时间和医院住院时间。
检索并筛选了 699 篇全文文章。纳入了 16 项纳入 3225 名危重症患者的随机对照试验。与所有其他类型的营养支持相比,ICU 入院后 24 小时内开始肠内营养并未降低死亡率(比值比,1.01;95%置信区间,0.86-1.18;p = 0.91;I = 32%)。然而,预先确定的亚组之间存在差异治疗效果(p = 0.032):与延迟肠内摄入相比,早期肠内营养降低了死亡率(比值比,0.45;95%置信区间,0.21-0.95;p = 0.038;I = 0%),而早期肠内营养与肠外营养之间未检测到死亡率差异(比值比,1.04;95%置信区间,0.89-1.22;p = 0.58;I = 30%)。总体而言,接受早期肠内营养的患者发生肺炎的可能性较小(比值比,0.75;95%置信区间,0.60-0.94;p = 0.012;I = 48%)。
总体而言,早期肠内营养与所有其他形式的营养支持之间无差异。预先计划的亚组分析显示,与延迟肠内摄入相比,早期肠内营养降低了死亡率和肺炎发生率;然而,早期肠内营养并没有明显优于肠外营养的临床优势。